Literature DB >> 15580467

[Acute disseminated encephalomyelitis. Pathogenesis, diagnosis, treatment, and prognosis].

O Stüve1, S Nessler, H P Hartung, B Hemmer, H Wiendl, B C Kieseier.   

Abstract

Acute disseminated encephalomyelitis (ADEM) is typically a monophasic, demyelinating disease of the CNS that predominantly affects children. Typically, its clinical symptoms follow an infection or vaccination. In this regard, numerous viral and bacterial pathogens as well as several vaccinations have been associated with ADEM. Studies from animal models suggest that primary and secondary autoimmune responses may contribute to CNS inflammation and demyelination in ADEM. The diagnosis of ADEM is strongly suggested by a close temporal relationship between a viral infection or immunization and the onset of neurologic symptoms, and it is supported by extensive, multifocal, subcortical white-matter disease on brain magnetic resonance imaging. While mild lymphocytic pleocytosis and elevated proteins are detectable in the CSF in ADEM, oligoclonal bands are not always present. Treatment of this disorder consists of anti-inflammatory and immunosuppressive therapies, and the prognosis is generally considered favorable.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15580467     DOI: 10.1007/s00115-004-1842-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  63 in total

1.  Acute disseminated encephalomyelitis associated with poliomyelitis vaccine.

Authors:  S C Arya
Journal:  Pediatr Neurol       Date:  2001-04       Impact factor: 3.372

2.  Acute disseminated encephalomyelitis following dengue fever.

Authors:  Yuuji Yamamoto; Tomohiko Takasaki; Ken-ichiro Yamada; Mikio Kimura; Kazushige Washizaki; Kouki Yoshikawa; Akihiro Hitani; Tetsuya Nakamura; Aikichi Iwamoto
Journal:  J Infect Chemother       Date:  2002-06       Impact factor: 2.211

Review 3.  Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis.

Authors:  O Stüve; S S Zamvil
Journal:  Curr Opin Neurol       Date:  1999-08       Impact factor: 5.710

4.  Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin.

Authors:  D J Sahlas; S P Miller; M Guerin; M Veilleux; G Francis
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

5.  A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Brain       Date:  1999-12       Impact factor: 13.501

6.  Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS?

Authors:  A Tourbah; O Gout; R Liblau; O Lyon-Caen; C Bougniot; M T Iba-Zizen; E A Cabanis
Journal:  Neurology       Date:  1999-07-22       Impact factor: 9.910

7.  Acute disseminated encephalomyelitis (ADEM) due to Mycoplasma pneumoniae infection in an adolescent.

Authors:  K Riedel; V A Kempf; A Bechtold; M Klimmer
Journal:  Infection       Date:  2001-08       Impact factor: 3.553

8.  Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins.

Authors:  Eli Shahar; Jameel Andraus; David Savitzki; Giora Pilar; Nathaniel Zelnik
Journal:  J Child Neurol       Date:  2002-11       Impact factor: 1.987

9.  Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis.

Authors:  M Nishikawa; T Ichiyama; T Hayashi; K Ouchi; S Furukawa
Journal:  Pediatr Neurol       Date:  1999-08       Impact factor: 3.372

10.  Acute disseminated encephalomyelitis in middle-aged or elderly patients.

Authors:  P N Wang; J L Fuh; H C Liu; S J Wang
Journal:  Eur Neurol       Date:  1996       Impact factor: 1.710

View more
  5 in total

Review 1.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

Review 2.  [Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

3.  Severe chorea with positive anti-basal ganglia antibodies after herpesencephalitis.

Authors:  I Marschitz; S Rödl; U Gruber-Sedlmayr; A Church; G Giovannoni; G Zobel; C J Mache; J Raith; B Plecko
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

Review 4.  Transverse myelitis.

Authors:  Shin C Beh; Benjamin M Greenberg; Teresa Frohman; Elliot M Frohman
Journal:  Neurol Clin       Date:  2013-02       Impact factor: 3.806

5.  Disseminated inflammation of the central nervous system associated with acute hepatitis E: a case report.

Authors:  Jan Rahmig; Arne Grey; Marco Berning; Jochen Schaefer; Martin Lesser; Heinz Reichmann; Volker Puetz; Kristian Barlinn; Timo Siepmann
Journal:  BMC Neurol       Date:  2020-10-27       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.